Search
Facial Treatments
Body Treatments
Injectables
Plastic Surgery
Your Esthetic Advisor
Beauty and Lifestyle Magazine
Facial Treatments
Body Treatments
Injectables
Plastic Surgery
Home
Tags
Analysts
Tag: Analysts
Injectables
[Top K-Pharma Analysis ⑰] Analysts show high expectations for PharmaResearch, citing the global expansion of Rejuran – KBR
Esthetic Advisor
-
July 24, 2023
0
Injectables
Analysts Predict Bullish Trend for Revance Therapeutics – Best Stocks
Esthetic Advisor
-
June 10, 2023
0
Injectables
Revance Therapeutics, Inc. (NASDAQ:RVNC) Receives Average Rating of “Moderate Buy” from Analysts
Esthetic Advisor
-
December 13, 2022
0
Injectables
Analysts have given Revance Therapeutics, Inc. (NASDAQ:RVNC) an average recommendation of “Moderate Buy.”
Esthetic Advisor
-
November 6, 2022
0
Injectables
Revance Therapeutics, Inc. (NASDAQ:RVNC) Given Average Recommendation of “Moderate Buy” by Analysts
Esthetic Advisor
-
October 24, 2022
0
Injectables
Revance Therapeutics, Inc. (NASDAQ:RVNC) Given Average Rating of “Moderate Buy” by Analysts
Esthetic Advisor
-
September 29, 2022
0
Injectables
Revance Therapeutics (NASDAQ:RVNC) Price Target Increased to $35.00 by Analysts at Guggenheim
Esthetic Advisor
-
August 16, 2022
0
Injectables
Analysts Set Revance Therapeutics, Inc. (NASDAQ:RVNC) Price Target at $25.00
Esthetic Advisor
-
August 13, 2022
0
Injectables
Revance Therapeutics, Inc. (NASDAQ:RVNC) Receives Average Recommendation of “Hold” from Analysts
Esthetic Advisor
-
May 15, 2022
0
Facial Treatments
Analysts Expect Nu Skin Enterprises, Inc. (NYSE:NUS) Will Announce Quarterly Sales of $610.69 Million
Esthetic Advisor
-
May 15, 2022
0
1
2
Page 1 of 2